Pelvic ischemia is measurable and symptomatic in patients with coronary artery disease: A novel application of dynamic contrast-enhanced magnetic resonance imaging

Journal of Sexual Medicine

Volumn 5, Issue 11, 2008, Pages 2635-2645

  De, Elise J B ^a   Hou, Ping ^b   Estrera, Anthony L ^b   Sdringola, Stefano ^b   Graves, Daniel E ^c   Westney, O Lenaine ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Magnetic resonance imaging; Pelvis; Perfusion

Indexed keywords

GADODIAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORPUS CAVERNOSUM; HUMAN; IMAGE ANALYSIS; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIC DISEASE; PELVIC ISCHEMIA; PRIORITY JOURNAL; PROSTATE; SCORING SYSTEM; TISSUE PERFUSION;

EID: 55949115657     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00969.x     Document Type: Article

References (53)

1. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischemic coronary disease correlate with erectile dysfunction? Int J Impot Res 1997; 9: 123-6.
2. Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: New guidelines for sexual medicine. J Sex Med 2006; 3: 28-36.
3. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R. Erectile dysfunction is a marker for cardiovascular disease: Results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005; 2: 40-52.
4. Broderick GA, Arger P. Duplex Doppler ultrasonography: Noninvasive assessment of penile anatomy and function. Semin Roentgenol 1993; 28: 43-56.
5. Berger AP, Bartsch G, Deibl M, Albert H, Pachinger O, Fritschert G, Rantner B, Fraedrich G, Pallwein L, Aigner F, Horninger W, Frauscher F. Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int 2006; 98: 1038-42.
6. Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003; 229: 248-54.
7. Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE. Dynamic contrast enhanced MRI of prostate cancer: Correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55: 99-109.
8. Mayr NA, Yuh WTC, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, Davis CS, Wen BC, Martin DD, Pelsang RE, Buller RE, Oberley LW, Mellenberg DE, Hussey DH. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: A new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996; 36: 623-33.
9. Coenegrachts K, Van Steenbergen WV, De Keyzer FD, Vanbeckevoort D, Bielen D, Chen F, Dockx S, Maes F, Bosmans H. Dynamic contrast-enhanced MRI of the pancreas: Initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004; 20: 990-7.
10. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005; 53: 249-55.
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile function. Urology 1997; 49: 822-30.
12. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57.
13. Hou P, De EJB, Kramer LA, Westney OL. Dynamic contrast-enhanced MRI study of male pelvic perfusion at 3T: Preliminary clinical report. J Magn Reson Imaging 2007; 25: 160-9.
14. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170: 843-50.
15. Persson K, Andersson KE. Non-adrenergic, non-cholinergic relaxation and levels of cyclic nucleotides in rabbit lower urinary tract. Eur J Pharmacol 1994; 268: 159-67.
16. Takeda M, Tang R, Shapiro E, Burnett AL, Lepor H. Effects of nitric oxide on human and canine prostates. Urology 1995; 45: 440-6.
17. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 1993; 91: 437-42.
18. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
19. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res 2003; 15: 246-52.
20. Kaiser FE, Viosca SP, Morley JE, Mooradian AD, Davis SS, Korenman SG. Impotence and aging: Clinical and hormonal factors. J Am Geriatr Soc 1988; 36: 511-9.
21. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323-34.
22. Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ, Park K, Park H, Hyun JS. Prevalence and risk factors for erectile dysfunction in Korean men: Results on an epidemiologic study. J Sex Med 2007; 4: 1269-76.
23. El-Sakka A. Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med 2007; 4: 1691-700.
24. Eyada M, Atwa M. Sexual function in female patients with unstable angina or non-ST-elevation MI. J Sex Med 2007; 4: 1373-80.
25. Borgquist R, Gudmundsson P, Winter R, Nilsson P, Willenheimer R. Erectile dysfunction in healthy subjects predicts reduced coronary blood flow velocity reserve. Int J Cardiol 2006; 112: 166-70.
26. Pritzker M. The penile stress test: A window to the hearts of man? Circulation 1999; 100 (I suppl): I-711.
27. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22-6.
28. Solomon H, Man JW, Wierzbicki AS, Jackson G. Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 2003; 91: 230-1.
29. Junemann KP, Aufenanger J, Konrad T, Pill J, Persson-Junemann C, Alken P. The effect of impaired lipid metabolism on the smooth muscle cells of rabbits. Urol Res 1991; 19: 271-5.
30. Wingard C, Fulton D, Husain S. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 2007; 4: 348-62.
31. Behr-Roussel D, Darblade B, Oudot A, Compagnie S, Barnabe J, Alexandre L, Giuliano F. Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice. J Sex Med 2006; 3: 596-603.
32. Xie D, Kontos CD, Donatucci CF, Annex BH. Cholesterol feeding reduces vascular endothelial growth factor signaling in rabbit corporal tissues. J Sex Med 2005; 2: 634-40.
33. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 2005; 173: 318-23.
34. Vallancien G, Emberton M, Harving N, Jeroen R, van Moorselaar A; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003; 169: 2257-61.
35. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC. Sildenafil influences lower urinary tract symptoms. BJU Int 2002; 90: 836-9.
36. Tarcan T, Azadzoi KM, Siroky MB, Goldstein I, Krane RJ. Age-related erectile and voiding dysfunction: The role of arterial insufficiency. Br J Urol 1998; 82 (I suppl): 26-33.
37. Diokno AC, Brock BM, Herzog AR, Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology 1990; 36: 129-38.
38. Shaley M, Richter S, Kessler O, Shpitz B, Fredman B, Nissenkorn I. Long-term incidence of acute myocardial infarction after open and transurethral resection of the prostate for benign prostatic hyperplasia. J Urol 1999; 161: 491-3.
39. Hahn RG, Yin L, Ekengren J, Sandfeldt L. Vascular endothelial growth factor in serum indicates cardiovascular risk in urology patients. Scand J Urol Nephrol 2006; 40: 144-8.
40. Kershen RT, Azadzoi KM, Siroky MB. Blood flow, pressure and compliance in the male human bladder. J Urol 2002; 168: 121-5.
41. Bercovich E, Barabino G, Pirozzi-Farina F. Age related fibrosis is the main factor of urinary symptoms in benign prostate hypertrophy (BPH) in patients. J Urol 1999; 161: 235; Abstract 903.
42. Masuda H, Yano M, Sakai Y, Kihara K, Goto M, Azuma H. Roles of accumulated endogenous nitric oxide synthase inhibitors and decreased nitric oxide synthase activity for impaired trigonal relaxation with ischemia. J Urol 2003; 170: 1415-20.
43. Saito M, Yokoi K, Ohmura M, Kondo A. Effects of ligation of the internal iliac artery on blood flow to the bladder and detrusor function in the rat. Int Urol Nephrol 1998; 30: 283-92.
44. Gill HS, Monson FC, Wein AJ, Ruggieri MR, Levin RM. The effects of short-term in-vivo ischemia on the contractile function of the rabbit urinary bladder. J Urol 1988; 139: 1350-4.
45. Azadzoi KM, Tarcan T, Siroky MB, Krane RJ. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol 1999; 161: 1626-35.
46. Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB. Overactivity and structural changes in the chronically ischemic bladder. J Urol 1999; 16: 1768-78.
47. Ghafar MA, Anastasiadis AG, Olsson LE, Chichester P, Kaplan SA, Buttyan R, Levin RM. Hypoxia and an angiogenic response in the partially obstructed rat bladder. Lab Invest 2002; 82: 903-9.
48. Greenland JE, Brading AF. The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs. J Urol 2001; 165: 245-8.
49. Lemack GE, Burkhard F, Zimmern PE, McConnell JD, Lin VK. Physiologic sequelae of partial infravesical obstruction in the mouse: Role of inducible nitric oxide synthase. J Urol 1999; 161: 1015-22.
50. Saito M, Yokoi K, Ohmura M, Kondo A. Effect of ischemia and partial outflow obstruction on rat bladder function. Urol Res 1997; 25: 207-11.
51. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: Endothelial dysfunction is the common denominator. Heart 2003; 89: 251-4.
52. Kazemi-Saleh D, Pishgou B, Assari S, Tavallaii SA. Fear of intercourse in patients with coronary artery disease: A pilot study of associated morbidity. J Sex Med 2007; 4: 1619-25.
53. El-Sakka A, Morsy A, Fagih B. Enhanced counterpulsation in patients with coronary artery disease-associated erectile dysfunction. Part I: Effects of risk factors. J Sex Med 2007; 4: 771-9.